StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Exact Sciences (EXAS) Set to Open Higher by 20% Following Promotional Agreement with Pfizer (PFE) for Cologuard
August 22, 2018 8:42 AM
Exact Sciences (NASDAQ: EXAS) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Momentum Movers
Trader Talk
Next Articles
Pfizer (PFE), Astellas Pharma Inc. Reports Amendments to Clinical Research Protocols for Two Phase 3 Trials of Enzalutamide
August 22, 2018 5:01 PM
Exact Sciences (EXAS) Adds 'Serious Firepower' with Pfizer Cologuard Deal - William Blair
August 22, 2018 9:09 AM
Exact Sciences to host conference call and webcast to discuss its Cologuard co-promotion agreement with Pfizer
August 22, 2018 6:15 AM
Exact Sciences (EXAS) Announces U.S. Promotional Agreement with Pfizer (PFE) for Cologuard
August 22, 2018 6:09 AM